preloader

Executive Board

Intro text: 

The Executive Board provides overall leadership for the organization, meeting several times a year to develop BIG’s scientific strategy, carry out decisions of the General Assembly, and provide oversight for the association.  BIG Board members are active in the BIG member groups and may serve up to two terms of 4 years each.  Half of any available seats are filled through direct election by the General Assembly and half are appointed by the Board.

Martine Piccart-Gebhart, MD, Phd

Functie: 
Chair

Intro: 

BIG Chair
Oncologist – Belgium

Carlos Barrios, MD

Functie: 
Member of the executive board

Intro: 

Oncologist - Brazil 

Philippe Bedard, MD

Functie: 
Member of the executive board

Intro: 

Oncologist - Canada

Judith Bliss, MSc

Functie: 
Member of the executive board

Intro: 

Biostatistician – United Kingdom

Etienne Brain, MD, Phd

Functie: 
Member of the executive board

Intro: 

Oncologist - France

David Cameron, MD

Functie: 
Member of the executive board

Intro: 

Oncologist – United Kingdom

Eva Carrasco, MD

Functie: 
Member of the executive board

Intro: 

Oncologist - Spain

Boon Chua, MD

Functie: 
Member of the executive board

Intro: 

Radiation oncologist – Australia

Read the latest interview

Marco Colleoni, MD

Functie: 
Member of the executive board

Intro: 

Oncologist – Italy

Angelo Di Leo, MD, Phd

Functie: 
Member of the executive board

Intro: 

Oncologist – Italy

Barbro Linderholm, MD, Phd

Functie: 
Member of the executive board

Intro: 

Oncologist – Sweden

Sibylle Loibl, MD, Phd

Functie: 
Member of the executive board

Intro: 

Gynaecologist – Germany

Shinji Ohno, MD, Phd

Functie: 
Member of the executive board

Intro: 

Surgeon – Japan

Aleix Prat, MD, Phd

Functie: 
Member of the executive board

Intro: 

Oncologist –  Spain

Nick Turner, MD, Phd

Functie: 
Member of the executive board

Intro: 

Oncologist - United Kingdom

Ander Urruticoechea, MD, Phd

Functie: 
Member of the executive board

Intro: 

Oncologist – Spain